Aethlon Medical, Inc. (AEMD) Stock Analysis & Investment Frameworks
Aethlon Medical, Inc. (AEMD) stock analysis on Invetso. Review Aethlon Medical, Inc.’s key financial metrics, company overview and 10 institutional-grade investment frameworks including SWOT Analysis, Economic Moat, Porter’s Five Forces and the Invetso Quality Score.
Aethlon Medical, Inc. Company Overview
- Exchange: NASDAQ Capital Market
- Sector: Healthcare
- Industry: Medical - Devices
- Country: US
Aethlon Medical, Inc. Key Financial Metrics
- Market Cap: $805869.00
- Revenue: $N/A
- ROE: -123.09%
- ROIC: -127.19%
- Dividend Yield: N/A
About Aethlon Medical, Inc.
Aethlon Medical, Inc. operates as a medical technology enterprise, dedicated to innovating solutions for the diagnosis and treatment of life-threatening and organ-jeopardizing diseases within the United States. Central to its pipeline is the Aethlon Hemopurifier, a clinical-stage immunotherapeutic device. This device is engineered to clear the human circulatory system of detrimental tumor-derived exosomes and perilous viruses. Notably, this capability extends to targeting the COVID-19 virus, its various strains, and associated exosomes. Furthermore, Aethlon Medical maintains a collaborative partnership with the University of Pittsburgh Medical Center's Hillman Cancer Center, conducting studies pertinent to head and neck cancer. Established in 1999, the company is headquartered in San Diego, California.
Aethlon Medical, Inc. Investment Frameworks
Invetso analyzes Aethlon Medical, Inc. (AEMD) across the following frameworks:
- Aethlon Medical, Inc. 10Y Growth Potential
- Aethlon Medical, Inc. Scenario Analysis
- Aethlon Medical, Inc. Risks & Opportunities
- Aethlon Medical, Inc. Economic Moat
- Aethlon Medical, Inc. Business Model
- Aethlon Medical, Inc. Management
- Aethlon Medical, Inc. SWOT Analysis
- Aethlon Medical, Inc. Porter's 5 Forces
- Aethlon Medical, Inc. PESTLE Analysis
- Aethlon Medical, Inc. ESG Analysis